12/05/2017 6o Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών Βαλβιδοπαθειών | G.Latsios | 4. What is the reasonable training path for an IC to TAVR today?

 
1,137 VIEWS EXPANDCOLLAPSE

Share

181,813 total
535 live
1,137 video
83,671 photo
Views:

08:30-11:00 TAVR: The astonishing first decade
Πρόεδροι: D.Cokkinos,S.Pattakos,S.Foussas,N.Ioannou
08:30-08:50 1. The foundation of a new therapy based on RCTs: The TAVR paradigm
A.Manginas
08:50-09:10 2. TAVR: The device evolution and the clinical outcomes improvements in the first decade
K.Spargias
09:10-09:30 3. TAVR: The constantly changing patient eligibility criteria. Past, current and future directions
K.Toutouzas
09:30-09:50 4. What is the reasonable training path for an IC to TAVR today?
G.Latsios
09:50-10:10 5. What is the reasonable training path for a CTS to TAVR today?
K.Bellos
10:10-10:30 6. Who should be performing TAVR today? Do Doctors and Patients interests concur?
A.Manolis
10:30-10:50 7. TAVI live case-in-a-box
I.Iakovou
10:50-11:00 Συζήτηση


 
Sort by Date | Views
Watch live and on demand the '6th Conference of  Transcatheter Heart Valve Therapies'.
​
The Diagnostic and Therapeutic Center of Athens Hygeia organizes the '6th Conference of  Transcatheter Heart Valve Therapies' that will take place from 12 to 13 May 2017, at Hilton Hotel in Athens, Greece.

For more information please click here.

Παρακολουθήστε ζωντανά και on demand το '6ο Συνέδριο Διαδερμικής Θεραπείας Καρδιακών Βαλβιδοπαθειών'.

Το Διαγνωστικό Θεραπευτικό Κέντρο Αθηνών ΥΓΕΙΑ διοργανώνει το '6o Συνέδριο Διαδερμικής Θεραπείας Καρδιακών Βαλβιδοπαθειών' στις 12 - 13 Μαΐου 2017 στο ξενοδοχείο Hilton στην Αθήνα.

Για περισσότερες πληροφορίες, πατήστε εδώ.
A.Manginas | 1. The foundation of a new... 1.138
K.Spargias | 2. TAVR: The device evolution... 1.218
K.Toutouzas | 3. TAVR: The constantly changing... 1.046
G.Latsios | 4. What is the reasonable training... 1.137
K.Bellos | 5. What is the reasonable training... 1.057
A.Manolis | 6. Who should be performing... 1.764
I.Iakovou | 7. TAVI live case-in-a-box 1.272
S.Pattakos 1.016
460
D.Cokkinos 1.173
A.Kartapanis 999
I.Goudevenos 1.014
Στρατής Παττακός | Καρδιοχειρουργός, Διευθυντής... 1.288
1:24
Στέφανος Φούσας | Σ. Διευθυντής - Ε. Καθηγητής... 900
2:31
C.Mourmouris | 1. MSCT screening. Guidance,... 971
Catherine Avgeropoulou, Cardiologist, Director,... 1.055
1:49
Konstantinos Toutouzas | Associate Professor... 1.299
2:08
G.Latsios | 2. TF access today: vessel,... 943
Gregory Pavlides | MD, PhD, FACC, FESC, Professor... 1.115
2:08
N.Bouboulis | 3. Unanimous verdict: non... 963
V.Tzifos | 4. Concomitant coronary artery... 963
E.Skalidis | 5. The advanced renal failure... 1.073
K.Toutouzas | 6. The procedure was flawless... 1.043
K.Spargias | 7. TAVR live-in-a-box 1.078
C.Avgeropoulou | 1. A “Physiologist’s” view... 1.126
C.Chrysohoou | 2. From clinical practice... 1.081
G.Makos | 4. MR Surgery. When to repair... 1.089
G.Pavlides | 5. Trancatheter MV replacement.... 1.039
K.Spargias | 6. MAC and ViV, ViR 998
K.Spargias | 7. Mitraclip case-in-a-box 1.129
K.Spargias | 1. The “standardized” TAVR... 862
Konstantinos Spargias | Director, Transcatheter... 1.461
1:56
George Dangas | FESC, FACC, Professor of... 1.072
2:10
L.Papavasileiou | 2. Pacemaker need after... 990
A.Kostopoulou | 3. Pacemaker indication:... 1.226
J.Velianou | 4. Why I want to move to lower... 1.024
V. Andoutsopoulou | 5. What bothers me to... 1.282
G.Dangas | 6. Antiplatelet/anticoagulation... 1.117
C.Arampatzis | 7. My best and worst TAVR... 993
K.Raisakis | 1. My best and worst TAVR case... 1.144
V.Tzifos | 2. My best and worst TAVR case... 1.061
P.Davlouros | 3. My best and worst TAVR... 1.126
M.Ηamilos | 4. My best and worst TAVR case... 847
A.Zacharoulis | 5. My best and worst TAVR... 944
A.Synetos | 6. My best and worst TAVR case... 1.150
K.Papadopoulos | 8. My best and worst TAVR... 1.057
Andreas Synetos | MD, PhD, FESC, Cardiologist,... 1.071
1:24
V.Ninios | 1. MitraClip patient selection-... 1.052
V.Ninios | 1. MitraClip patient selection-... 990
G.Pavlides | 3. Mitral interventions: a... 1.029
S.Pattakos | 6. Which “operable” DMR patient... 1.003
V.Ninios | 7. Mitraclip case-in-a-box 888
M.Vavouranakis | 1. How I select my TAVR... 988
K.Spargias | 2. How I select my TAVR device?... 967
D.Nikas | 4. How I select my TAVR device?... 970
D.Nikas | 4. How I select my TAVR device?... 746
Q&A / Comments 950
K. Papadopoulos - K.Spargias | 6. TAVR live-in-a-box 1.008
A.Gkouziouta | 1. The pathophysiology of... 1.132
I.Ikonomidis | 2. Assessing Tricuspid Regurgitation:... 1.080
P.Sfyridis | 3. The unforgotten valve: what... 939
V.Sachpekidis | 5. The multiple valve disease... 1.053
V.Ninios | 6. Mitraclip in TR 911
M.Chrissoheris | 7. FORMA in TR 1.001
G.Stavridis | 8. The isolated TR inoperable... 1.032
Q&A / Comments 1.022
VIDEO UNDER EDITING - L.Michalis | 1. TAVR:... 1.089
D.Angouras | 2. TAVR device durability.... 1.039
L.Poulimenos | 3. Paradox AVS: implications... 1.180
P.Dardas | 4. TAVR in Bicuspid and ViV 941
I.Iakovou | 5. VARC-2 and MVRC definitions 1.056
G.Bompas | 6. The concept of 4D imaging... 1.047
D.Nikas | 7. My best and worst TAVR case... 853
A.Ziakas | 3. My best and worst TAVR case... 1.109
N.Pilatis | 1. My best and worst TAVR case... 830
G.Karavolias | 4. My best and worst TAVR... 1.035
K.Kalogeras | 5. My best and worst TAVR... 794
D.Tsikaderis | 6. My best and worst TAVR... 1.062
A.Manginas | 7. My best and worst TAVR case... 1.049
P. Kourkoveli | 2. My best and worst TAVR... 1.019
Christina Chrysohoou, MD, Cardiologist,Heart... 961
49
Irene Mastorakou, Cardiac Radiologist,Director,... 880
123
Lampros Michalis, Professor of Cardiology,University... 1.190
49
James Velianou, MD, FRCPC,Interventional... 1.047
69
Georgios Katsimagklis, InterventionalCardiologist,... 1.346
109